Steven E Kahn Selected Research

Glycated Hemoglobin (Glycosylated Hemoglobin)

1/2022	Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.
1/2022	Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
1/2021	Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort.
9/2019	Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
8/2013	Glucose levels and risk of dementia.
12/2006	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven E Kahn Research Topics

Disease

98	Insulin Resistance 05/2024 - 04/2002
94	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2002
26	Obesity 05/2024 - 04/2002
23	Glucose Intolerance 01/2024 - 07/2002
18	Weight Loss (Weight Reduction) 05/2024 - 12/2006
17	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2010
12	Overweight 05/2024 - 06/2014
10	Hypertension (High Blood Pressure) 01/2022 - 10/2003
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 08/2004
9	Stroke (Strokes) 01/2024 - 04/2010
9	Amyloid Plaque 10/2022 - 02/2003
7	Myocardial Infarction 01/2024 - 04/2010
7	Hyperglycemia 11/2022 - 02/2002
7	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 03/2004
6	Prediabetic State (Prediabetes) 01/2023 - 06/2012
6	Heart Failure 01/2022 - 12/2006
5	Inflammation (Inflammations) 01/2024 - 03/2014
5	Non-alcoholic Fatty Liver Disease 11/2019 - 03/2005
4	Body Weight (Weight, Body) 01/2024 - 09/2010
4	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2002
4	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 05/2008
4	Chronic Renal Insufficiency 01/2019 - 02/2013
4	Alzheimer Disease (Alzheimer's Disease) 02/2013 - 11/2005
3	COVID-19 07/2023 - 12/2021
3	Heart Diseases (Heart Disease) 01/2023 - 01/2018
3	Albuminuria 01/2022 - 01/2018
3	Unstable Angina 11/2021 - 04/2010
3	Diabetes Mellitus 01/2019 - 07/2015
3	Cognitive Dysfunction 05/2017 - 11/2005
3	Weight Gain 03/2015 - 12/2006
3	Liver Diseases (Liver Disease) 10/2010 - 03/2005
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 11/2022
2	Amyloidosis 12/2023 - 10/2017
2	Proteinuria 09/2021 - 01/2021
2	AIDS-Related Complex (ARC) 01/2021 - 10/2017
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 02/2013
2	Abdominal Obesity 01/2020 - 02/2009
2	Pancreatitis 09/2019 - 01/2019
2	Kidney Diseases (Kidney Disease) 01/2019 - 01/2016
2	Neoplasms (Cancer) 01/2017 - 03/2004

Drug/Important Bio-Agent (IBA)

102	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 07/2002
56	Insulin (Novolin)FDA Link 05/2024 - 02/2002
36	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 10/2002
22	Amyloid (Amyloid Fibrils)IBA 01/2024 - 02/2003
18	Islet Amyloid PolypeptideIBA 01/2024 - 02/2002
13	Triglycerides (Triacylglycerol)IBA 01/2021 - 04/2003
12	LipidsIBA 05/2024 - 09/2003
9	C-Reactive ProteinIBA 01/2018 - 10/2002
9	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
8	LinagliptinIBA 09/2021 - 07/2013
8	CholesterolIBA 01/2020 - 08/2003
7	glimepiride (Amarel)FDA LinkGeneric 01/2024 - 07/2013
7	C-PeptideIBA 01/2024 - 12/2004
7	LeptinIBA 01/2022 - 04/2002
7	HDL CholesterolIBA 01/2021 - 04/2003
7	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
6	Insulin Glargine (Lantus)FDA Link 01/2024 - 01/2021
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 12/2006
6	AdiponectinIBA 01/2021 - 03/2004
5	Peptides (Polypeptides)IBA 01/2022 - 08/2004
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2004
4	semaglutideIBA 05/2024 - 11/2020
4	Liraglutide FDA Link 01/2024 - 01/2022
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2024 - 01/2022
4	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2020
4	AlbuminsIBA 01/2021 - 10/2002
4	CreatinineIBA 01/2021 - 08/2007
4	EnzymesIBA 01/2019 - 10/2007
4	HDL LipoproteinsIBA 01/2019 - 12/2010
4	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 12/2006
4	Lipoproteins (Lipoprotein)IBA 06/2011 - 01/2003
4	ThiazolidinedionesIBA 01/2010 - 12/2006
3	ProinsulinIBA 05/2024 - 04/2007
3	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
3	CytokinesIBA 01/2022 - 12/2006
3	Apolipoproteins E (ApoE)IBA 01/2021 - 05/2017
3	AntigensIBA 01/2021 - 10/2002
3	IsotopesIBA 11/2015 - 02/2009
3	AdipokinesIBA 11/2015 - 03/2013
2	AutoantibodiesIBA 01/2024 - 01/2021
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2024 - 01/2021
2	tirzepatideIBA 01/2024 - 11/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 11/2021
2	Glucagon (Glukagon)FDA Link 01/2021 - 01/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2003
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2019 - 11/2007
2	LDL CholesterolIBA 01/2019 - 04/2003
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2008
2	IncretinsIBA 01/2018 - 05/2012
2	Protons (Proton)IBA 11/2015 - 10/2010
2	Antidepressive Agents (Antidepressants)IBA 03/2015 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 09/2014 - 03/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2014 - 07/2013
2	InflammasomesIBA 09/2014 - 10/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2014 - 12/2006

Therapy/Procedure

9	Glycemic Control 01/2024 - 10/2002
7	Therapeutics 01/2024 - 06/2004
4	Bariatric Surgery 03/2014 - 08/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006